79 results on '"Malhan S"'
Search Results
2. EE286 Cost Effectiveness and Public Health Impact of Implementing Gender-Neutral Vaccination with the 9-Valent Human Papillomavirus Vaccine in Turkiye
3. EE102 Economic Burden of Short-Acting Beta-2 Agonist Overuse Among Asthma Patients in Turkiye: A Cost Analysis with Respect to Updated Recommendations of the Global Initiative for Asthma
4. EE280 Economic Burden of Hyperkalemia in Turkey
5. EE193 The Health Impact Projection Model of the PD-1/PD-L1 Inhibitor Class in Cancer Care in Turkey
6. POSB146 Economic Burden of Migraine in Turkey
7. PRO45 NATIONAL BURDEN OF HEMOPHILIA A IN TURKEY
8. PRO57 COST MINIMIZATION ANALYSIS OF EMICIZUMAB IN THE PROPHYLAXIS OF INHIBITOR-NEGATIVE PATIENTS WITH HEMOPHILIA A IN TURKEY
9. PMS56 - COST-EFFECTIVENESS ANALYSIS OF SUBCUTANEOUS TOCILIZUMAB WITHOUT METHOTREXATE IN RHEUMATOID ARTHRITIS TREATMENT
10. PMS44 - COST-EFFECTIVENESS ANALYSIS OF SUBCUTANEOUS TOCILIZUMAB PLUS METHOTREXATE IN RHEUMATOID ARTHRITIS TREATMENT
11. PSS20 - ECONOMIC BURDEN OF PSORIASIS (PSO) IN TURKEY
12. PDB48 - ANNUAL COST OF ILLNESS OF ISCHEMIC STROKE IN TYPE 2 DIABETIC PATIENTS IN TURKEY
13. PDB52 - ANNUAL COST OF ACUTE MYOCARDIAL INFARCTION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS IN TURKEY
14. PCN152 - COST EFFECTIVENESS OF ALECTINIB IN THE FIRST LINE TREATMENT OF ADVANCED ALK-POSITIVE NON-SMALL CELL LUNG CANCER IN TURKEY
15. A Survey On The Society's Awareness Level On Aids In Turkey
16. Cost-Effectiveness Analysis of The Paliperidone Palmitate 3-Month Formulation Versus 1-Month Formulation From A Healthcare Payer Perspective
17. Cost-Effectiveness of Empagliflozin (Jardiance®) In The Treatment of Patients With Type 2 Diabetes Mellitus (T2DM) In Turkey Based Empa-Reg Outcome Data
18. Modelling The Burden Of Cardiovascular Disease In Turkey And The Impact Of Reducing Modifiable Risk Factors
19. The Economic Burden Of Acute Bacterial Rhinosinusitis And Acute Otitis Media In Turkey: An Epidemiology Based Cost Of Illness Study With Respect To Clinical Practice And Available Guidelines
20. Economic Burden of Gastric Cancer in Turkey
21. Type 2 Diabetes in Turkey – A Cost of Illness Study
22. Direct Cost Estimation of Psoriatic Arthritis Treatment In Turkey: Results From A Delphi Panel
23. Irrational Use of Antibiotics in Turkey
24. Economic Burden of Primary Immunodeficiency (PIDD) In Turkey
25. Annual Cost of Illness of Macular Edema (ME) Secondary to Branch Retinal Vein Occlusion (BRVO) in Turkey
26. Burden of Visual Impairment Due to Myopic Choroidal Neovascularisation (MCNV) in Turkey
27. Burden of Metastatic Castration-Resistant Prostate Cancer (MCRPC) in Turkey
28. Cost-Effectiveness of Intravitreal Aflibercept (IVT-AFL) in Treatment of Macular Edema (ME) Secondary to Branch Retinal Vein Occlusion (BRVO)
29. Direct Cost Estimation of Psoriasis Treatment in Turkey: Results from a Delphi Panel
30. Determination Of The Vaccine-Preventable Diseases Burden In Turkey In Terms Of Various Vaccination Policies
31. Cost Effectiveness of Pegfilgrastim for Reducing Incidence of Febrile Neutropenia Events after Cytotoxic Chemotherapy for Solid Tumors in Turkey
32. Dapagliflozin Versus a Dipeptidyl Peptidase 4 Inhibitor (DPP4) Both Added to Metformin in Patients with Type 2 Diabetes Mellitus (T2DM): Impact on Health, Quality of Life and Costs in the Turkish Clinical Setting
33. Importance of Hypoglycemia Barrier on The Treatment of Diabetes Mellitus (Dm) – Survey With Turkish Physicians
34. A Validity and Reliability Study of the Poverty Related Quality of Life Questionnaire in a Turkish Patient Population
35. Evaluation of Patients’ Quality of Life of Preoperation and Early Postoperation After Total Hip and Knee Arthroplasty
36. The Cost-Effectiveness Analysis for Hiv Treatment Alternatives in Turkey
37. The Effects of Reforms, Price Cuts and Global Budget Implementation on Biotechnological Medicine Sales Which Have Annual Average Highest Amount Of Sales Between 2008-2013 In Turkey
38. The Effects of Reforms, Price Cuts And Global Budget Implementation on Original/Generic Medicine Sales Which Have Annual Average Highest Amount Of Sales Between 2008-2013 In Turkey
39. Cost-Effectiveness of Exenatide Twice Daily (Bid) Added To Basal Insulin Compared To A Bolus Insulin Add-On In Turkey
40. Effects of Reference Price System on Medicines Which Have Annual Average Highest Amount Of Sales Of Between Years 2008-2013
41. Characteristics of The Medicines Which Have Annual Average Highest Amount Of Sales Of Between Years 2008-2013
42. Estimation of the Cost of Childhood Asthma in Turkey
43. A Cost-Effectiveness Evaluation for a New Therapy in HIV Treatment
44. The Direct Cost of Asthma in Turkey
45. Economic Burden in Direct Costs of Chronic Obstructive Pulmonary Disease (COPD) in Turkey: A Payor Perspective
46. Comparative analysis of direct cost studies on rheumatoid arthritis in Turkey
47. Comparative analysis of direct cost studies on ankylosing spondylitis (AS) in Turkey
48. PRS38 Turkish Cultural Adaptation and Validation of Smoking Cessation Quality of Life (SCQoL) Questionnaire
49. PIN59 Cost-Effectiveness of Amoxicillin Clavulanate Directed Towards the Application of Indicated at Primary Care in the Treatment of Community Acquired Pneumonia, Acute Rhinosinusitis, Tonsillopharyngitis, and Acute Otitis Media
50. PMD39 Cost Effectiveness Analysis of Intrathecal Baclofen Therapy (Tricumed™) Versus Medical Treatments for Severe Spasticity in Turkey
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.